Building a safer CAR-T therapy
Monday, February 3, 2020 - 16:00
in Health & Medicine
A new study has devised a new type of chimeric antigen-receptor (CAR) T cell -- a family of promising immunotherapies for cancer -- that can be switched on and off on demand.